INcreasing Statin Prescribing in HIV Behavioral Economics REsearch (INSPIRE)
Status
Conditions
Treatments
Details and patient eligibility
About
Cardiovascular disease is a major cause of morbidity and mortality among people living with HIV. Recent studies have demonstrated that patients with HIV experience a 50-100% increased risk of myocardial infarction and stroke compared to HIV-uninfected persons. They also face higher risks of stroke, sudden death, and heart failure. However, evidence-based statin therapy-which is safe in this population and highly effective at reducing cardiovascular risk-is under-prescribed. The investigators propose a multi-level intervention to increase evidence-based statin prescribing by addressing barriers at these levels. The implementation intervention includes two strategies: (1) tailored education at the leadership, provider, and patient levels, and (2) behavioral economics-informed feedback for providers.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- age ≥ 40 years
- have been diagnosed with HIV
- LDL ≥ 190, diabetes and LDL ≥ 70
- or 10-year ASCVD risk ≥ 7.5%
- or history of heart attack, stroke, or peripheral vascular disease
- care for patients with HIV at least 1/2 day each week (physicians)
- work at participating clinics (physicians)
Exclusion criteria
- unable to provide written, informed consent
- not at participating clinic
Trial design
Primary purpose
Allocation
Interventional model
Masking
75 participants in 3 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal